Omnicell [OMCL] vs Veeva Systems [VEEV] Detailed Stock Comparison
Omnicell
NASDAQ
Loading...
Veeva Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Omnicell wins in 7 metrics, Veeva Systems wins in 12 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Omnicell | Veeva Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 61.66 | 60.03 | Veeva Systems |
| Price-to-Book Ratio | 1.13 | 7.40 | Omnicell |
| Debt-to-Equity Ratio | 30.42 | 1.24 | Veeva Systems |
| PEG Ratio | 17.13 | 41.74 | Omnicell |
| EV/EBITDA | 18.92 | 49.00 | Omnicell |
| Profit Margin (TTM) | 2.01% | 27.34% | Veeva Systems |
| Operating Margin (TTM) | 2.80% | 30.79% | Veeva Systems |
| EBITDA Margin (TTM) | 2.80% | 30.79% | Veeva Systems |
| Return on Equity | 1.87% | 14.06% | Veeva Systems |
| Return on Assets (TTM) | 0.49% | 6.90% | Veeva Systems |
| Free Cash Flow (TTM) | $134.93M | $1.09B | Veeva Systems |
| 1-Year Return | -24.53% | 50.99% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 1.24 | 16.15 | Omnicell |
| Enterprise Value | $1.40B | $39.73B | Veeva Systems |
| EV/Revenue Ratio | 1.22 | 13.91 | Omnicell |
| Gross Profit Margin (TTM) | 43.94% | 77.10% | Veeva Systems |
| Revenue per Share (TTM) | $25 | $18 | Omnicell |
| Earnings per Share (Diluted) | $0.50 | $4.70 | Veeva Systems |
| Beta (Stock Volatility) | 0.78 | 0.96 | Omnicell |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Omnicell vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Omnicell | -0.64% | 3.60% | 3.94% | 21.43% | -27.29% | -30.44% |
| Veeva Systems | 0.85% | 0.28% | 0.53% | 17.78% | 18.64% | 33.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Omnicell | -24.53% | -71.93% | -56.14% | -15.02% | 165.78% | 269.66% |
| Veeva Systems | 50.99% | 25.19% | 9.21% | 1,018.23% | 535.57% | 535.57% |
Performance & Financial Health Analysis: Omnicell vs Veeva Systems
| Metric | OMCL | VEEV |
|---|---|---|
| Market Information | ||
| Market Cap | $1.43B | $46.10B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 653,530 | 1,155,088 |
| 90 Day Avg. Volume | 520,253 | 1,244,579 |
| Last Close | $30.83 | $282.13 |
| 52 Week Range | $22.66 - $55.75 | $183.70 - $296.72 |
| % from 52W High | -44.70% | -4.92% |
| All-Time High | $187.29 (Nov 22, 2021) | $343.96 (Aug 02, 2021) |
| % from All-Time High | -83.54% | -17.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.17% |
| Quarterly Earnings Growth | 0.51% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.27% |
| Operating Margin (TTM) | 0.03% | 0.31% |
| Return on Equity (TTM) | 0.02% | 0.14% |
| Debt to Equity (MRQ) | 30.42 | 1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.22 | $38.11 |
| Cash per Share (MRQ) | $8.69 | $37.14 |
| Operating Cash Flow (TTM) | $147.75M | $1.20B |
| Levered Free Cash Flow (TTM) | $85.81M | $1.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Omnicell vs Veeva Systems
| Metric | OMCL | VEEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 61.66 | 60.03 |
| Forward P/E | 17.13 | 41.74 |
| PEG Ratio | 17.13 | 41.74 |
| Price to Sales (TTM) | 1.24 | 16.15 |
| Price to Book (MRQ) | 1.13 | 7.40 |
| Market Capitalization | ||
| Market Capitalization | $1.43B | $46.10B |
| Enterprise Value | $1.40B | $39.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.22 | 13.91 |
| Enterprise to EBITDA | 18.92 | 49.00 |
| Risk & Other Metrics | ||
| Beta | 0.78 | 0.96 |
| Book Value per Share (MRQ) | $27.22 | $38.11 |
Financial Statements Comparison: Omnicell vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OMCL | VEEV |
|---|---|---|
| Revenue/Sales | $290.56M | $759.04M |
| Cost of Goods Sold | $162.88M | $173.82M |
| Gross Profit | $127.68M | $585.22M |
| Research & Development | $21.57M | $184.03M |
| Operating Income (EBIT) | $8.12M | $233.73M |
| EBITDA | $29.77M | $243.55M |
| Pre-Tax Income | $10.45M | $298.82M |
| Income Tax | $4.81M | $70.63M |
| Net Income (Profit) | $5.64M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OMCL | VEEV |
|---|---|---|
| Cash & Equivalents | $386.83M | $1.96B |
| Total Current Assets | $839.67M | $6.71B |
| Total Current Liabilities | $607.53M | $1.46B |
| Long-Term Debt | $199.72M | $66.57M |
| Total Shareholders Equity | $1.26B | $6.21B |
| Retained Earnings | $375.87M | $3.68B |
| Property, Plant & Equipment | $130.63M | $122.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OMCL | VEEV |
|---|---|---|
| Operating Cash Flow | $28.34M | $810.54M |
| Capital Expenditures | $-11.17M | N/A |
| Free Cash Flow | $10.19M | $877.16M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | OMCL | VEEV |
|---|---|---|
| Shares Short | 1.91M | 4.60M |
| Short Ratio | 4.36 | 3.62 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 653,530 | 1,155,088 |
| Average Daily Volume (90 Day) | 520,253 | 1,244,579 |
| Shares Outstanding | 46.38M | 162.58M |
| Float Shares | 44.85M | 149.92M |
| % Held by Insiders | 0.02% | 0.09% |
| % Held by Institutions | 1.05% | 0.87% |
Dividend Analysis & Yield Comparison: Omnicell vs Veeva Systems
| Metric | OMCL | VEEV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |